WNT surrogate molecules and uses thereof
US11773171B2 · kind B2 · utility
1Cited by
28References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 19, 2018 |
| Grant date | Oct 3, 2023 |
| Priority date | — |
| Expiry date | Jul 4, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/33
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides Wnt pathway agonists and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.